Stem Celll Agency Science Subcommittee Meeting 9/29/10

Sep 29, 2010
Main Location: 

CIRM
210 King Street
San Francisco, CA 94107

Additional Locations: 
Aldrich Hall University of California, Irvine Irvine, CA 92697-3175
330 Plaza Street Healdsburg, CA 95448
Reeve-Irvine Research Center 1105 Gillespie Neuroscience Research Facility (GNRF) 837 Health Science Road University of California at Irvine School of Medicine Irvine, CA 92697-4292
City of Hope 1500 E. Duarte Road Duarte, California 91010
Klein Financial Corporation 550 California Avenue, Suite 330 Palo Alto, CA 94306
ValleyCare Health System 5575 West Las Positas Blvd. Suite 300 Pleasanton, CA 94588
University of Washington Paul G. Allen Center for Computer Science & Engineering 185 Stevens Way Seattle WA 98195

Stem Cell Agency Science Subcommittee Meeting

MEETING NOTICE AND AGENDA

SCIENCE SUBCOMMITTEE
OF THE INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE

Organized Pursuant to the
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

1. Call to Order

2. Roll Call

[Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]

3. Continued discussion of and consideration of changes to Extraordinary Petition and Grant Administration Appeals processes.
a. Extraordinary Petition Process Option A / Posting Applications
b. Extraordinary Petition Process Option B / Additional Analysis
c.Extraordinary Petition Process Option C / Limited Investigation

4. Discussion of proposal for programmatic scoring of grant applications by Patient Advocate members of Grants Working Group for inclusion in discussions and decisions regarding applications.

5. Consideration of process for approving use of unused disease team research award grant round funds for research that goes beyond the scope of the original RFAs.
a.BACKGROUND: Expansion of Disease Team I Activities (Presented by staff to Board at August 18-19 ICOC Meeting)

6. Discussion of Pre-Application Process, including but not limited to the process generally and scientific feedback to applicants who are not successful in the process.

7. Public comment.

8. Adjournment

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.
**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov .
 

© 2013 California Institute for Regenerative Medicine